RxDoctor Payments Data

Vinai Gondi, MD

Radiation Oncology · Warrenville, ILNPI 1457516395

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,315 of the $32,402 with a category attached, or 87.4%. Servier Pharmaceuticals LLC accounts for 68.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $30,522, more than ten times the $485 reported in 2019. Among radiation oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,402in general payments, 2019–2025

Across 21 payments — averaging $1542.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Servier Pharmaceuticals LLC$22K
  • AstraZeneca$7K
  • Accuray Incorporated$3K
  • Raysearch Laboratories AB (publ)$485
  • Novocure Inc.$375
$306,343in research payments, 2019–2025

Across 64 payments — averaging $4786.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$297K
  • Novocure Inc.$10K

What the payments were for

  • Consulting fees$28,31587%
  • Speaking & faculty fees$2,5008%
  • Travel & lodging$5882%
  • Food & beverage$9993%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,402 in reported general payments places this provider in the 95th percentile of 242 radiation oncology providers in Illinois.

See all radiation oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$299,557
Medicare patients
480
Services billed
2,494

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam25$805
Dexamethasone33$536

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Warrenville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →